Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Comis

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
British Journal of Cancer|October 1, 1993
Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamideP J O'Dwyer, F P LaCreta, J Walczak, et al.
Cancer Research|April 1, 1982
Detection of a serum DNA-binding protein associated with cancerL Galvan, J E Evans, R L Comis, et al.
Cancer Research|July 1, 1988
A phase I study of recombinant interleukin 2 plus recombinant beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Cancer Research|April 15, 1991
Phase I pharmacokinetic study of intraperitoneal etoposideP J O'Dwyer, F P LaCreta, J P Daugherty, et al.
Journal of Virology|February 1, 1985
Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytesJ L Moore, B J Poiesz, K W Zamkoff, et al.
Cancer Research|December 1, 1979
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patientsR L Comis, M S Kuppinger, S J Ginsberg, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Medical and Pediatric Oncology|January 1, 1979
Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysisJ C D'Aoust, A W Prestayko, L H Einhorn, et al.
Journal of the National Cancer Institute|January 16, 1991
Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factorR L Krigel, K A Padavic-Shaller, A A Rudolph, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1984
Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapyJ A Meyer, P M Ikins, J J Gullo, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
British Journal of Cancer|October 1, 1993
Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamideP J O'Dwyer, F P LaCreta, J Walczak, et al.
Cancer Research|April 1, 1982
Detection of a serum DNA-binding protein associated with cancerL Galvan, J E Evans, R L Comis, et al.
Cancer Research|July 1, 1988
A phase I study of recombinant interleukin 2 plus recombinant beta-interferonR L Krigel, K A Padavic-Shaller, A R Rudolph, et al.
Cancer Research|April 15, 1991
Phase I pharmacokinetic study of intraperitoneal etoposideP J O'Dwyer, F P LaCreta, J P Daugherty, et al.
Journal of Virology|February 1, 1985
Inverse relationship between constitutive gamma interferon production and human T-cell lymphoma/leukemia virus expression in cultured T lymphocytesJ L Moore, B J Poiesz, K W Zamkoff, et al.
Cancer Research|December 1, 1979
Role of single-breath carbon monoxide-diffusing capacity in monitoring the pulmonary effects of bleomycin in germ cell tumor patientsR L Comis, M S Kuppinger, S J Ginsberg, et al.
American Journal of Clinical Oncology|October 1, 1990
Phase II trial of carboplatin in soft-tissue sarcomaD Goldstein, B Cheuvart, D L Trump, et al.
Medical and Pediatric Oncology|January 1, 1979
Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: an analysisJ C D'Aoust, A W Prestayko, L H Einhorn, et al.
Journal of the National Cancer Institute|January 16, 1991
Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factorR L Krigel, K A Padavic-Shaller, A A Rudolph, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 1, 1984
Histologic alterations in small cell carcinoma of the lung after two cycles of intensive chemotherapyJ A Meyer, P M Ikins, J J Gullo, et al.
Pageof 12